Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.
Science
; 378(6620): 619-627, 2022 11 11.
Статья
в английский
| MEDLINE | ID: covidwho-2078696
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages carry distinct spike mutations resulting in escape from antibodies induced by previous infection or vaccination. We show that hybrid immunity or vaccine boosters elicit plasma-neutralizing antibodies against Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5, and that breakthrough infections, but not vaccination alone, induce neutralizing antibodies in the nasal mucosa. Consistent with immunological imprinting, most antibodies derived from memory B cells or plasma cells of Omicron breakthrough cases cross-react with the Wuhan-Hu-1, BA.1, BA.2, and BA.4/5 receptor-binding domains, whereas Omicron primary infections elicit B cells of narrow specificity up to 6 months after infection. Although most clinical antibodies have reduced neutralization of Omicron, we identified an ultrapotent pan-variant-neutralizing antibody that is a strong candidate for clinical development.
Полный текст:
Имеется в наличии
Коллекция:
Международные базы данных
база данных:
MEDLINE
Основная тема:
Antibodies, Neutralizing
/
Immune Evasion
/
Spike Glycoprotein, Coronavirus
/
SARS-CoV-2
/
COVID-19
/
Antibodies, Viral
/
Antibody Formation
Тип исследования:
Прогностическое исследование
/
Рандомизированные контролируемые испытания
Темы:
Вакцина
/
Варианты
Пределы темы:
Люди
Язык:
английский
Журнал:
Science
Год:
2022
Тип:
Статья
Аффилированная страна:
Science.adc9127
Документы, близкие по теме
MEDLINE
...
LILACS
LIS